(Q28199932)

https://api.crossref.org/works/10.1016%2FS0166-4328%2800%2900361-2

7 January 2021

The panicogenic effects of cholecystokinin-tetrapeptide are antagonized by L-365,260, a central cholecystokinin receptor antagonist, in patients with panic disorder

1 reference

https://api.crossref.org/works/10.1016%2FS0166-4328%2800%2900361-2

7 January 2021

Enhanced sensitivity to cholecystokinin tetrapeptide in panic disorder. Clinical and behavioral findings

1 reference

https://api.crossref.org/works/10.1016%2FS0166-4328%2800%2900361-2

7 January 2021

Glutamate-dopamine interactions in the ventral striatum: role in locomotor activity and responding with conditioned reinforcement.

1 reference

https://api.crossref.org/works/10.1016%2FS0166-4328%2800%2900361-2

7 January 2021

Microinjections of phencyclidine (PCP) and related drugs into nucleus accumbens shell potentiate medial forebrain bundle brain stimulation reward.

1 reference

https://api.crossref.org/works/10.1016%2FS0166-4328%2800%2900361-2

7 January 2021

Antidepressant-like effects of CCKB antagonists in mice: antagonism by naltrindole

1 reference

https://api.crossref.org/works/10.1016%2FS0166-4328%2800%2900361-2

7 January 2021

Existence of striatal nerve cells coexpressing CCK(B) and D2 receptor mRNAs

1 reference

https://api.crossref.org/works/10.1016%2FS0166-4328%2800%2900361-2

7 January 2021

Antidepressant-like effects of CCK(B) receptor antagonists: involvement of the opioid system

1 reference

https://api.crossref.org/works/10.1016%2FS0166-4328%2800%2900361-2

7 January 2021

Morphine place conditioning is differentially affected by CCKA and CCKB receptor antagonists.

1 reference

https://api.crossref.org/works/10.1016%2FS0166-4328%2800%2900361-2

7 January 2021

Blockade of morphine place conditioning by the CCKA receptor antagonist devazepide.

1 reference

https://api.crossref.org/works/10.1016%2FS0166-4328%2800%2900361-2

7 January 2021

Autoradiographic localization and biochemical characterization of peripheral type CCK receptors in rat CNS using highly selective nonpeptide CCK antagonists

1 reference

https://api.crossref.org/works/10.1016%2FS0166-4328%2800%2900361-2

7 January 2021

Differential Gene Expression of CCK(A) and CCK(B) Receptors in the Rat Brain

1 reference

https://api.crossref.org/works/10.1016%2FS0166-4328%2800%2900361-2

7 January 2021

Cholecystokinin-B receptor antagonists attenuate morphine dependence and withdrawal in rats.

1 reference

https://api.crossref.org/works/10.1016%2FS0166-4328%2800%2900361-2

7 January 2021

Inhibition of morphine withdrawal by the association of RB 101, an inhibitor of enkephalin catabolism, and the CCKB antagonist PD-134,308

1 reference

https://api.crossref.org/works/10.1016%2FS0166-4328%2800%2900361-2

7 January 2021

From motivation to action: functional interface between the limbic system and the motor system.

1 reference

https://api.crossref.org/works/10.1016%2FS0166-4328%2800%2900361-2

7 January 2021

Structure of porcine cholecystokinin-pancreozymin. 1. Cleavage with thrombin and with trypsin

1 reference

https://api.crossref.org/works/10.1016%2FS0166-4328%2800%2900361-2

7 January 2021

G protein-coupled cholecystokinin-B/gastrin receptors are responsible for physiological cell growth of the stomach mucosa in vivo

1 reference

https://api.crossref.org/works/10.1016%2FS0166-4328%2800%2900361-2

7 January 2021

Quantitative autoradiographic localization of cholecystokinin receptors in rat and guinea pig brain using 125I-Bolton-Hunter-CCK8.

1 reference

https://api.crossref.org/works/10.1016%2FS0166-4328%2800%2900361-2

7 January 2021

CCK-B receptor: chemistry, molecular biology, biochemistry and pharmacology

1 reference

https://api.crossref.org/works/10.1016%2FS0166-4328%2800%2900361-2

7 January 2021

Endogenous opiates: 1994.

1 reference

https://api.crossref.org/works/10.1016%2FS0166-4328%2800%2900361-2

7 January 2021

Autoradiography of CCK receptors in the rat brain using [(3)H]Boc[Nle(28)(31)]CCK(27)-(33) and [(125)I]bolton-hunter CCK(8). Functional significance of subregional distributions.

1 reference

https://api.crossref.org/works/10.1016%2FS0166-4328%2800%2900361-2

7 January 2021

A circuitry model of the expression of behavioral sensitization to amphetamine-like psychostimulants

1 reference

https://api.crossref.org/works/10.1016%2FS0166-4328%2800%2900361-2

7 January 2021

Cholecystokinin (CCK)-like material and CCK mRNA levels in the rat brain and spinal cord after acute or repeated morphine treatment

1 reference

https://api.crossref.org/works/10.1016%2FS0166-4328%2800%2900361-2

7 January 2021

NMDA receptors in the nucleus accumbens modulate intravenous cocaine but not heroin self-administration in the rat

1 reference

https://api.crossref.org/works/10.1016%2FS0166-4328%2800%2900361-2

7 January 2021

The molecular nature of vascularly released cholecystokinin from the isolated perfused porcine duodenum

1 reference

https://api.crossref.org/works/10.1016%2FS0166-4328%2800%2900361-2

7 January 2021

Extracellular dopamine in the anterior nucleus accumbens is distinctly affected by ventral tegmental area administration of cholecystokinin and apomorphine: data from in vivo voltammetry

1 reference

https://api.crossref.org/works/10.1016%2FS0166-4328%2800%2900361-2

7 January 2021

On the mechanism(s) of cholecystokinin (CCK): receptor stimulation attenuates morphine dependence in mice

1 reference

https://api.crossref.org/works/10.1016%2FS0166-4328%2800%2900361-2

7 January 2021

Association of enkephalin catabolism inhibitors and CCK-B antagonists: a potential use in the management of pain and opioid addiction

1 reference

https://api.crossref.org/works/10.1016%2FS0166-4328%2800%2900361-2

7 January 2021

Opposite role of CCKA and CCKB receptors in the modulation of endogenous enkephalin antidepressant-like effects

1 reference

https://api.crossref.org/works/10.1016%2FS0166-4328%2800%2900361-2

7 January 2021

Cholecystokinin and morphine analgesia: variations on a theme

1 reference

https://api.crossref.org/works/10.1016%2FS0166-4328%2800%2900361-2

7 January 2021

Microinjections of nanogram amounts of sulfated cholecystokinin octapeptide into the rat nucleus accumbens attenuates brain stimulation reward.

1 reference

https://api.crossref.org/works/10.1016%2FS0166-4328%2800%2900361-2

7 January 2021

Antagonism of cholecystokinin function in the rostral and caudal nucleus accumbens: differential effects on brain stimulation reward.

1 reference

https://api.crossref.org/works/10.1016%2FS0166-4328%2800%2900361-2

7 January 2021

Weak tolerance to the antinociceptive effect induced by the association of a peptidase inhibitor and a CCKB receptor antagonist

1 reference

https://api.crossref.org/works/10.1016%2FS0166-4328%2800%2900361-2

7 January 2021

The attenuation of morphine-conditioned place preference following chronic mild stress is reversed by a CCKB receptor antagonist.

1 reference

https://api.crossref.org/works/10.1016%2FS0166-4328%2800%2900361-2

7 January 2021

Cholecystokinin in mammalian primary sensory neurons and spinal cord: in situ hybridization studies in rat and monkey

1 reference

https://api.crossref.org/works/10.1016%2FS0166-4328%2800%2900361-2

7 January 2021

Cholecystokinin modulates both the development and the expression of behavioral sensitization to amphetamine in the rat

1 reference

https://api.crossref.org/works/10.1016%2FS0166-4328%2800%2900361-2

7 January 2021

Electrical stimulation of the prefrontal cortex increases cholecystokinin, glutamate, and dopamine release in the nucleus accumbens: an in vivo microdialysis study in freely moving rats.

1 reference

https://api.crossref.org/works/10.1016%2FS0166-4328%2800%2900361-2

7 January 2021

10.1016/S0166-4328(00)00361-2

Identifiers

DOI

1 reference

Consolidated OpenCitations Corpus – April 2017

1 reference

Consolidated OpenCitations Corpus – April 2017

PubMed publication ID

11173090

1 reference

Consolidated OpenCitations Corpus – April 2017